Apitope

Topas Therapeutics

This biotechnology company develops nanoparticle-based therapeutics that induce immune tolerance to treat patients with autoimmune diseases, allergies and anti-drug immune responses.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

immunique

This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.

Toleranzia

This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.

GentiBio

GentiBio develops engineered regulatory T cell therapies to restore immune tolerance for patients with autoimmune, alloimmune, autoinflammatory and allergic diseases.

APLS

This biopharmaceutical company develops complement-based therapies to treat autoimmune and inflammatory diseases for patients with conditions like paroxysmal nocturnal haemoglobinuria and geographic atrophy.

Tolerance Bio, Inc.

This biopharmaceutical company develops thymus-based therapies to treat immune-mediated diseases including cancer, autoimmunity and transplant rejection for patients requiring restored immune tolerance.